This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The ABCs of Medicare: Prescription Drug Plans

Editor's note: This is the third in a series of three stories on Medicare. The first part compared the relative benefits of original Medicare and Medicare Advantage; the second part discussed the different kinds of supplemental coverage, or Medigap, available to people who use original Medicare.

Let's move onto Medicare Part D, which is the part that is entering open enrollment this month. Part D represents prescription drug coverage offered by private providers.

If you have selected original Medicare, then you will need to choose a stand-alone prescription drug plan from one of these providers. If you are using a Medicare Advantage plan, then in most likelihood your insurer includes the drug coverage as part of the plan.

While minimum coverage is mandated by Medicare, plans may offer better coverage in terms of lower deductibles, out-of-pocket limits and access to medications in the gap between the initial coverage limit and out-of-pocket threshold (often referred to as the "donut hole"). (The standard benefit parameters for 2008, as compared with 2007, are listed at the end of this article.)

If you have been using a stand-alone prescription drug plan for the last year or two, then you have enough information to make a more educated decision in choosing a plan this time around. If you spent more than $3,600 out of pocket (or if you will by year-end), then you need to look at plans that don't require a deductible to be met and have coverage in the so-called "donut-hole" or coverage gap.

While you probably selected your current plan on the basis of the monthly premium, in this case you would be better off paying a higher premium for a plan that offers more complete coverage.

You will want to use the Medicare Prescription Drug Plan comparison tool at to get a complete list of plans in your area. You can check out Terry Savage's article for more details about the tool.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AET $104.06 0.00%
CVS $94.63 0.00%
HNT $63.88 0.00%
HUM $168.90 0.00%
UNH $114.34 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs